Clinical Trial Highlights

• Sifalimumab Slows Disease Activity in SLE
• GR Agonist Improves Responses in RA
• Preventing GC-Induced Bone Loss in Women with RA
• Lesinurad Provides Additional Lowering of SUA in Gout
• Infliximab Biosimilar Appears Safe and Effective Compared with Infliximab for RA
• Flare-Free Withdrawal of TNFis Possible in Patients with RA and Stable Low Disease Activity
• APR Improves PsA Symptoms Out to Week 104
• Triple Therapy More Cost-effective than Biologic First in Patients Who Fail MTX
• Efficacy of Secukinumab Sustained over Time for Treatment of Active PsA
• FUTURE 1: Secukinumab Inhibits Radiographic Disease Progression in PsA
• Negative Results End Development Program of Treating JIA with GLM
• MEASURE 1: Secukinumab an Effective Treatment for Active AS